Retraction

Patients sous palbociclib et hormonothérapie pour un cancer du sein métastatique: peut-on prédire la survenue d’une hématotoxicité précoce et sévère? [Patients treated with palbociclib and endocrine therapy for metastatic breast cancer: Can we predict the occurrence of severe early hematological toxicity?]

Paper Information

Record ID:
49678
Publication Date:
April 02, 2021
Retraction Date:
May 11, 2021 (4.5 years years ago)
Article Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

date of retraction unknown, html page overwrite; see also: https://pubpeer.com/publications/E22C6D04F1E019565F537E3DC5A315#

Citations (2)

2
Total Citations
1
Post-Retraction
(50.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
51 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Palbociclib
Unknown Authors
Reactions Weekly
Published: Jul 2021
51 days after retraction
Quick Stats
Total Citations: 2
Years Since Retraction: 4.5 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers